Filing Flows › Theriva Biologics (TOVX) › How it makes money
How Theriva Biologics (TOVX) makes money
Theriva Biologics (TOVX) made $300K of revenue in the first quarter 2026 (Q1 2026).
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q1 2026 | % of revenue |
|---|---|---|
| Revenue | $300K | 100.0% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q1 2026 | $300K | — |
From Theriva Biologics' 10-Q filed May 5, 2026 (on EDGAR).
Questions
How does Theriva Biologics make money?
Theriva Biologics (TOVX) made $300K of revenue in the first quarter 2026 (Q1 2026).
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.